Park Ha Biological Technology Co., Ltd. Price & Performance (PHH)

Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) has experienced a significant year-to-date rise in its stock price, climbing 68.52% since its IPO in late December 2024. The company’s focus on personalized skincare products in China, a growing market, has attracted investor interest, fueling optimism for its future growth.123

Since its initial public offering at $4 per share, Park Ha Biological Technology Co., Ltd. has seen its stock price nearly double. The firm raised $4.8 million from the IPO, which it plans to use for expanding operations and reducing production costs. Investor confidence remains high amid its strategic growth plans.435

Park Ha Biological Technology Co., Ltd. has emerged as a notable defensive stock in 2025. Amid economic uncertainties, its focus on essential skincare products has drawn investors seeking stability. With a 68.52% year-to-date gain, PHH exemplifies the shift toward defensive investments in volatile markets.267